Over 1 million Triathlon Cementless Knees implanted globally MAHWAH, N.J., Sept. 21, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, continues its year of milestones celebration with the 10th anniversary of the Triathlon Tritanium baseplate. Since its introduction in 2013, Triathlon Cementless, which includes the Triathlon Tritanium Baseplate, has delivered a decade of positive...Read more
The company's newest Simplera™ CGM is 50% smaller than its previous generation with a simple insertion and improved user experience DUBLIN, Sept. 21, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced CE (Conformité Européenne) Mark approval for its new all-in-one, disposable Simplera™ continuous glucose monitor (CGM) featuring a simple, two-step insertion process....Read more
Abbott to commercialize several biosimilar molecules in key emerging markets in Latin America, Southeast Asia, the Middle East and Africa Spain-based global biotech leader mAbxience Holdings S.L. to develop, manufacture and supply the biosimilar molecules First molecules expected to launch as early as 2025, offering new treatment options that leverage the latest in scientific breakthroughs for people in emerging markets ABBOTT...Read more
Solution seamlessly delivers proprietary technology, real world data and analytics, aligning to industry security and data privacy standards DUBLIN / Sep 20, 2023 / Business Wire / ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial Tokenisation solution. The combination of ICON’s proprietary tokenisation engine, access to...Read more
Stryker’s PROstep MIS portfolio will be featured at the American Orthopaedic Foot & Ankle Society Annual Meeting KALAMAZOO, Mich. / Sep 19, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced the launch of PROstep® MIS Lapidus, a new internal fixation system intended for treating bunions using a minimally invasive surgical reduction of hallux valgus deformity and subsequent...Read more
New agreement aims to provide greater access to millions more high-quality tuberculosis (TB) tests for people living in the least developed countries where the need is most urgent. Enables the Global Fund to provide Cepheid's Xpert® MTB/RIF Ultra diagnostic test cartridges for TB at cost, with no profit to Danaher. WASHINGTON, Sept. 19, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher"), a global science and technology...Read more
Acquisition intended to expand neuromodulation portfolio to provide more treatment options for people living with chronic low back pain MARLBOROUGH, Mass., Sept. 19, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Relievant Medsystems, Inc., a privately held medical technology company that has developed and commercialized the Intracept® Intraosseous...Read more
The #1 prescribed continuous glucose monitoring (CGM) system1 now connects to the #1 doctor-recommended weight management plan2 to help people living with diabetes understand how food and activity impact their glucose levels WeightWatchers Diabetes-Tailored Plan members can now see key glucose data3,4,5 from Abbott's FreeStyle Libre® 2 system within the WW app6 ABBOTT PARK, Ill. and NEW YORK, Sept. 19, 2023 /PRNewswire/ --...Read more
Abbott introduced the world's first ablation catheter with a flexible tip and contact force technology, used to perform an ablation procedure to treat atrial fibrillation (AFib) First successful treatment in Canada - Abbott's innovative technology enables physicians to have better visualization allowing for more accuracy and precision, leading to reduced procedure times and better safety MISSISSAUGA, ON, Sept. 19, 2023 /CNW/ --...Read more
Stryker's 1788 camera platform brings enhanced technology to the operating room – including a wider color gamut, more vivid white light and new fluorescence imaging capabilities SAN JOSE, California, USA, Sept. 14, 2023 /PRNewswire/ -- Stryker (NYSE: SYK), one of the world's leading medical technology companies, today unveiled the next-generation of minimally invasive surgical cameras: the 1788 platform. The fully enhanced camera is...Read more
BURLINGTON, N.C., Sept. 14, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, is hosting an Investor Day beginning at 1:00 p.m. ET today in New York City, expected to conclude by approximately 4:00 p.m. ET. The event will highlight the company's go-forward strategy from Labcorp Chairman & CEO Adam Schechter, followed by business overviews and a longer-term financial...Read more
DUBLIN / Sep 13, 2023 / Business Wire / ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces that it is partnering with the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, to execute a clinical trial to evaluate the effectiveness of...Read more
Pangea to offer a comprehensive and versatile portfolio, providing variable-angle plating for a variety of patient populations KALAMAZOO, Mich. / Sep 12, 2023 / Business Wire / Stryker (NYSE: SYK), one of the world’s leading medical technology companies, announced that its Pangea Systems including Femur, Fibula, Tibia, Humerus and Utility have received 510k clearance from the U.S. Food & Drug Administration. “FDA clearance is a...Read more
Resolution Bioscience’s blood-based diagnostic tests complement Exact Sciences’ Precision Oncology portfolio, providing a more complete cancer treatment solution for patients, healthcare professionals, and biopharma partners SANTA CLARA, Calif. & MADISON, Wis. / Sep 12, 2023 / Business Wire / Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests,...Read more
Alcon Vivity Registry continues to demonstrate excellent outcomes with AcrySof IQ Vivity and AcrySof IQ Vivity Toric, the first and only PCIOL+ with wavefront-shaping technology World-renowned surgeons will present new registry data at #ESCRS2023, including data on rates of visual disturbances1,2 Registry monitored 900+ cataract patients post-surgery, including those with certain mild comorbidities GENEVA / Sep 09, 2023 / Business...Read more
CARLSBAD, Calif., Sept. 7, 2023 /PRNewswire/ -- Navigate BioPharma Services, Inc., a specialty laboratory offering high-quality, innovative precision medicine solutions and bioanalytics for clinical development and diagnostic applications, announces a strategic collaboration with BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, to explore opportunities to develop and commercialize flow...Read more
New stroke risk reduction therapy with thromboresistant coating is designed to advance procedural performance and safety MARLBOROUGH, Mass., Sept. 6, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration approval for the latest-generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure (LAAC) Device. Designed to further advance the procedural performance...Read more
Plan Editor is a new tool in the Plan stage of the Align digital workflow that enables enhanced flexibility and customization in Invisalign treatment planning for Invisalign trained orthodontists and general practitioner (GP) dentists. Complements Align’s automated treatment planning templates, allowing doctors to quickly make broad, macro modification, exceptions, or to deviate, if needed, from their treatment planning templates for a...Read more
LAS VEGAS & SAN JOSE, Calif. & TEMPE, Ariz. & VIENNA / Sep 06, 2023 / Business Wire / Align Technology, Inc. (Align) (Nasdaq: ALGN) today announced that it has entered into a definitive agreement to acquire privately held Cubicure GmbH, a pioneer in direct 3D printing solutions for polymer additive manufacturing that develops, produces, and distributes innovative materials, equipment, and processes for novel 3D printing...Read more
AlignTM Oral Health Suite including future collaboration with X-Ray Insights will Aid Doctors in Identifying and Educating Patients on Oral Health Conditions and Improve Their Oral Health iTero-exocad ConnectorTM Upcoming Release Will Optimize Doctor and Lab Collaboration and Productivity by Streamlining Case Communication in a Single Channel on the MyiTeroTM Portal LAS VEGAS & PETACH TIKVA, Israel & SAN JOSE, Calif. &...Read more
Bigfoot developed Bigfoot Unity, a smart insulin management system that features the first and only FDA-cleared connected insulin pen caps that turn data from a continuous glucose monitor (CGM) into clear and reliable insulin dosing recommendations displayed right on the insulin pen cap Acquisition will bring together two leaders in different aspects of diabetes care: CGM and insulin injection support Together, Abbott and Bigfoot will...Read more
SAN DIEGO, Sept. 5, 2023 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced that its Board of Directors has appointed Jacob Thaysen, Ph.D., senior vice president of Agilent Technologies and president of its Life Sciences and Applied Markets Group, as Chief Executive Officer, effective September 25, 2023. Mr. Thaysen's extensive background and experience in...Read more
The NTrainer™ System 2.0 is the only FDA Class II biofeedback device designed to help newborns and infants born prematurely develop their non-nutritive sucking skills needed for independent oral feeding. DUBLIN, Ohio, Aug. 30, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today the launch of its next generation NTrainer™ System 2.0, a medical device designed to help premature and newborn infants develop the oral...Read more
WASHINGTON, Aug. 28, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Abcam plc (NASDAQ: ABCM), a leading global supplier of protein consumables, pursuant to which Danaher will acquire all of the outstanding shares of Abcam for $24.00 per share in cash, or a total enterprise value of...Read more
IRVINE, Calif., Aug. 28, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) today announced it is scheduled to present at the 2023 Wells Fargo Healthcare Conference on Thursday, September 7, 2023. Bernard Zovighian, chief executive officer, and Scott B. Ullem, chief financial officer, are scheduled to speak to conference attendees at 11:00 a.m. ET. A live webcast of the presentation will be available to all...Read more
SAN DIEGO / Aug 28, 2023 / Business Wire / DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring, today announced the appointment of Rimma Driscoll to its Board of Directors, effective August 24, 2023. Ms. Driscoll is an accomplished leader with significant experience developing, guiding and executing organic and inorganic growth strategies for global organizations. She currently serves as Executive Vice...Read more
Noninferiority established through high treatment success, low adverse event rates Findings presented at ESC Congress 2023 and simultaneously published in The New England Journal of Medicine MARLBOROUGH, Mass. and AMSTERDAM, Aug. 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month results from the pivotal ADVENT clinical trial of the FARAPULSE™ Pulsed Field Ablation (PFA) System*, a...Read more
Inceptiv automatically and instantly adjusts therapy based on signals from the spinal cord DUBLIN, Aug. 25, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, has received CE (Conformité Européenne) Mark approval for its Inceptiv™ closed-loop rechargeable spinal cord stimulator (SCS). It is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological...Read more
SANTA CLARA, Calif. / Aug 24, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the issuing of a companion diagnostic (CDx) Class C IVDR certification for PD-L1 IHC 22C3 pharmDx, Code SK006. This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices (IVDR). PD-L1 IHC 22C3 pharmDx, Code SK006,...Read more
BOSTON and NEW YORK, Aug. 24, 2023 /PRNewswire/ -- Advent International ("Advent"), one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, today announced they have selected Franco Negron to be chief executive officer (CEO) of BioPharma Solutions (BPS) following its proposed divestiture from Baxter International Inc. (NYSE:BAX). The closing of the...Read more
DUBLIN, Aug. 23, 2023 /PRNewswire/ -- Today, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation (RDN) System. The panel Committee voted unanimously (13-0) on safety and in favor (7-6) of the effectiveness of the Symplicity blood pressure procedure. The Committee's vote was...Read more
Broad strength across businesses and geographies results in mid-single digit revenue growth, driven by execution, innovation, and improved underlying fundamentals DUBLIN, Aug. 22, 2023 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its first quarter of fiscal year 2024 (FY24), which ended July 28, 2023. Key Highlights Revenue of $7.7 billion increased 4.5% as reported and 6.0% organic GAAP diluted...Read more
SAN DIEGO, Aug. 17, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the opening of a new office and state-of-the-art Illumina Solutions Center in Bengaluru, India. Illumina's expansion comes after 16 years of working closely with the company's channel partner in India, Premas Life Sciences. Now with its own permanent facility, Illumina will continue...Read more
Second quarter 2023 sales of $2.4 billion, up 9%, or 12% constant currency(1) (cc) Second quarter 2023 diluted EPS of $0.34, up 13%, or up 34% cc; core diluted EPS(2) of $0.69 up 10%, or 19% cc Based on strong operational performance and improved outlook, Company raises full year 2023 sales and core diluted EPS guidance GENEVA / Aug 15, 2023 / Business Wire / Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its...Read more
Fourth quarter revenue increased 13% to $53.5 billion Fourth quarter GAAP1 operating earnings were $137 million and GAAP diluted loss per share was $0.25 Fourth quarter non-GAAP operating earnings increased 24% to $560 million and non-GAAP diluted EPS increased 48% to $1.55 Fourth quarter Pharmaceutical segment profit increased 12% to $504 million and Medical segment profit increased to $82 million Generated both operating cash...Read more
CONSHOHOCKEN, Pa. / Aug 15, 2023 / Business Wire / AmerisourceBergen Corporation (NYSE: ABC) today announced that its Board of Directors has elected Werner Baumann and Lauren M. Tyler as new independent directors, effective October 1, 2023. With the election of Mr. Baumann and Ms. Tyler, the Board of Directors will increase from ten to twelve members, ten of whom are independent. “We look forward to welcoming Mr. Baumann and Ms. Tyler to...Read more
Advances World-Class Clinical Research Capabilities with Leading Regulatory-Grade Registries Platform Expected to Be Accretive to Adjusted Earnings Per Share1 WALTHAM, Mass. / Aug 14, 2023 / Business Wire / Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today announced that it has completed the acquisition of CorEvitas, LLC (“CorEvitas”), a leading provider of regulatory-grade,...Read more
Revenue of $1.18 billion for Q2 2023, up 1% from Q2 2022 (up 3% on a constant currency basis) and up 8% from Q1 2023 Shipped 109 NovaSeq X instruments in Q2 2023; boosting our supply capacity to more than 390 instruments for fiscal year 2023 GAAP diluted loss per share of $(1.48) for Q2 2023, compared to GAAP diluted loss per share of $(3.40) for Q2 2022, which included $609 million in legal contingencies Non-GAAP diluted earnings...Read more
First-of-its-kind expandable cryoballoon catheter advances cryoablation therapy, addresses key limitations with traditional systems MARLBOROUGH, Mass., Aug. 8, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the POLARx™ Cryoablation System. The new system, which is indicated for the treatment of patients with paroxysmal atrial...Read more
Year-over-year revenue grows 23%, operating profit up 8%, non-GAAP operating profit up 13% Quarterly dividend increases 9% to $0.48 per share A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Aug. 03, 2023 (GLOBE NEWSWIRE) -- ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended June 30, 2023. Fourth Quarter 2023...Read more
Kalamazoo, Michigan, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the second quarter of 2023: Second Quarter Results Reported net sales increased 11.2% to $5.0 billion Organic net sales increased 11.9% Reported operating income margin of 19.3% Adjusted operating income margin(1) increased 60 bps to 24.3% Reported EPS increased 12.2% to $1.93 Adjusted EPS(1) increased 12.9% to...Read more
Continues Strong Performance and Progress Toward Achieving BD 2025 Strategy; Advances Innovation Pipeline and Receives Clearance for Updated BD Alaris™ Infusion System Revenue of $4.9 billion increased 5.1% as reported and 6.3% on a currency-neutral basis Revenue from base business (which excludes COVID-only diagnostic testing) grew 6.7% as reported, 7.9% currency-neutral or 6.3% organic GAAP and adjusted diluted EPS from continuing...Read more
Labcorp Expands Diagnostic Testing and Laboratory Services in Eastern Massachusetts to Increase Access, Affordability and Standardized Testing Labcorp and Tufts Medicine have entered into an agreement for Labcorp to acquire the Tufts Medicine Outreach Laboratory Business and select operating assets This transaction – an initial component of an envisioned larger strategic partnership – will expand patient specimen collection access in...Read more
IRVING, Texas / Aug 02, 2023 / Business Wire / McKesson Corporation (NYSE: MCK) has released its fiscal 2024 first quarter financial results. Results can be accessed on McKesson’s Investor Relations website at investor.mckesson.com/financials/quarterly-results. As previously announced, the company will host a live webcast of the earnings conference call for investors today, Wednesday, August 2nd at 4:30 PM ET to review its financial...Read more
DUBLIN, IRELAND, Aug. 02, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced that it has completed the previously announced acquisition of the surgical instrumentation, laparoscopic instrumentation and sterilization container assets from BD (Becton, Dickinson and Company) (NYSE:BDX). “We are pleased to announce the closing of this acquisition, as the brands we are adding will strengthen,...Read more
Revenue of $66.9 billion for the Third Quarter, an 11.5 Percent Increase Year-Over-Year Third Quarter GAAP Diluted EPS of $2.35 and Adjusted Diluted EPS of $2.92 Adjusted Diluted EPS Guidance Range Raised to $11.85 to $11.95 for Fiscal 2023 Company will begin operating as Cencora and trading under the ticker symbol “COR,” effective August 30, 2023 CONSHOHOCKEN, Pa. / Aug 02, 2023 / Business Wire / AmerisourceBergen Corporation...Read more
First quarter revenue growth of 11% as reported and constant currency organic As reported diluted earnings per share increased to $1.25; adjusted earnings increased to $2.00 Fiscal 2024 outlook updated to reflect acquisition of BD surgical instrumentation assets DUBLIN, IRELAND, Aug. 01, 2023 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2024 first...Read more
Revenue of $3,728 million grew 5.3 percent year-over-year on a reported basis and 5.5 percent at constant currency GAAP Net Income of $297 million grew 16.0 percent year-over-year Adjusted EBITDA of $864 million grew 8.0 percent year-over-year GAAP Diluted Earnings per Share of $1.59 grew 18.7 percent year-over-year Adjusted Diluted Earnings per Share of $2.43 declined 0.4 percent year-over-year R&D Solutions quarterly bookings...Read more
Records second quarter revenue growth of 10% reported and 10% organic, driven by CAG Diagnostics recurring revenue growth of 11% reported and 12% organic Achieves record second quarter global premium instrument placements, supporting 11% annual installed base growth Delivers EPS of $2.67, representing 71% growth as reported and 77% on a comparable basis, including 54% of EPS growth rate benefit from lapping of discrete R&D...Read more
Single Test on BD MAX™ System Identifies and Differentiates Multiple Respiratory Infectious Diseases from One Sample FRANKLIN LAKES, N.J., Aug. 1, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the BD Respiratory Viral Panel (RVP) for BD MAX™ System, a single molecular diagnostic...Read more
SAN DIEGO / Jul 27, 2023 / Business Wire / DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended June 30, 2023. Second Quarter 2023 Financial Highlights: Revenue grew 25% versus the same quarter of the prior year to $871.3 million on a reported basis and 26% on an organic1 basis. U.S. revenue growth of 21% and international revenue growth of 38% on a reported basis. International revenue...Read more
MARLBOROUGH, Mass., July 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated net sales of $3.599 billion during the second quarter of 2023, growing 11.0 percent on a reported basis, 12.0 percent on an operational1 basis and 11.6 percent on an organic2 basis, all compared to the prior year period. The company reported GAAP net income attributable to Boston Scientific common stockholders of $261 million or...Read more
Second-quarter revenues increased 3% on a reported basis and 4% on a constant currency basis, ahead of the company’s previously issued guidance1 Second-quarter U.S. GAAP earnings (loss) per share (EPS) (including discontinued operations) of ($0.28); adjusted EPS (including discontinued operations) of $0.66 Second-quarter U.S. GAAP EPS from continuing operations of ($0.39); adjusted EPS from continuing operations of...Read more
Conference Call Scheduled for 9 a.m. EDT Today EXTON, Pa., July 27, 2023 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2023 and updated full-year 2023 financial guidance. Second-Quarter 2023 Summary (comparisons to prior-year period) Net sales of $753.8 million declined 2.3%; organic net sales declined 2.5%. Reported-diluted EPS of $2.06, compared to...Read more
Company Provides Full-Year Guidance Labcorp completed the spin-off of Fortrea on June 30, which is treated as discontinued operations in the historical financials Announced a $1.0 billion accelerated share repurchase program Drove growth through new and expanded healthcare system partnerships Second quarter revenue grew 4% versus last year as the Base Business grew 13%. Results from Continuing Operations for second quarter versus...Read more
IRVINE, Calif., July 26, 2023 /PRNewswire/ -- Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2023. Highlights and Outlook Q2 sales grew 11 percent to $1.53 billion; constant currency1 sales grew 12 percent All product groups achieved double digit constant currency sales growth in Q2 Q2 TAVR sales grew 9 percent; constant currency sales grew 10 percent Q2 EPS of $0.50...Read more
Better than expected revenues and operating margins reflect improving trends across regions Q2’23 Clear Aligner cases for teenagers increased 7% sequentially and 10% year over year, driven by momentum in both Submitters and Utilization and continued growth from Invisalign First™ Q2'23 total revenues of $1.0 billion, increased 6.3% sequentially and 3.4% year-over-year, and diluted net income per share of $1.46, non-GAAP diluted net...Read more
Highlights Net business wins in the quarter of $2,419 million; a net book to bill of 1.20 or 1.21 on a trailing twelve month basis. Closing backlog of $21.7 billion, an increase of 2.2% on quarter one 2023 or an increase of 8.5% on quarter two 2022. Quarter two revenue of $2,020.3 million representing an increase of 4.4% on prior year revenue and 4.3% on a constant currency organic basis. YTD revenue of $3,998.8 million...Read more
WALTHAM, Mass. / Jul 26, 2023 / Business Wire / Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended July 1, 2023. Second Quarter 2023 Highlights Second quarter revenue was $10.69 billion, 3% lower versus the same quarter last year. Core organic revenue growth was 2%. Second quarter GAAP diluted earnings per share (EPS) was $3.51. Second...Read more
ANAHEIM, Calif., July 25, 2023 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical chemistry offering and demonstrating ongoing commitment to product innovation in the in vitro diagnostic industry. Designed for small-to-medium-sized laboratories, the DxC 500 AU Chemistry Analyzer...Read more
WASHINGTON, July 25, 2023 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the second quarter 2023. Net earnings refer to net earnings attributable to common shareholders. For the quarter ended June 30, 2023 net earnings were $1.1 billion, or $1.49 per diluted common share and non-GAAP adjusted diluted net earnings per common share were $2.05. Revenues decreased 7.5% year-over-year...Read more
SAN DIEGO, July 25, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of Decision Medicine™, today announced a strategic partnership to make Pillar's suite of oncology assays commercially available globally as part of the Illumina portfolio of oncology products. The agreement will result in an unprecedented offering of complementary...Read more
ANAHEIM, Calif., July 25, 2023 /PRNewswire/ -- Beckman Coulter, a clinical diagnostics leader, today revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed, reliability, reproducibility, quality, and menu expansion. The DxI 9000 Analyzer has shown capability to develop increasingly sensitive and clinically relevant assays enabling the platform to keep...Read more
Labcorp's Menopause Test and Menopause Support Program provide women with insights to guide their healthcare decisions BURLINGTON, N.C., July 24, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it now offers menopause testing through its Labcorp OnDemand digital health platform. Approximately 1.3 million women enter menopause each year. While...Read more
FRANKLIN LAKES, N.J., July 24, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher, 63, was most recently the chief medical officer for Johnson & Johnson (J&J), serving in this capacity from 2012 until her retirement in 2023. As chief medical officer, she provided...Read more
Alliance aims to accelerate therapeutic development and expand the diversity of genomic data through inclusion of more samples from currently underrepresented ancestries SAN DIEGO, July 18, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, in collaboration with Nashville Biosciences, LLC, a leading clinical and genomic data company and wholly owned subsidiary of...Read more
BURLINGTON, N.C., July 13, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader in innovative and comprehensive laboratory services, today announced the completion of the previously announced transaction that establishes a strategic relationship with Jefferson Health (Jefferson), the largest health system serving the greater Philadelphia and Southern New Jersey region. "This groundbreaking agreement between Jefferson and Labcorp...Read more
2023 marks five years of industry-leading DRAGEN software offered by Illumina SAN DIEGO, July 11, 2023 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the launch of the latest version of DRAGEN™ software for analysis of next-generation sequencing data. DRAGEN 4.2 expands award-winning accuracy combined with its renowned flexibility and scalability to...Read more
Agreement Will Expand Access to Labcorp's Diagnostics Capabilities and Improve Services BURLINGTON, N.C., July 11, 2023 /PRNewswire/ -- Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced that it has entered into an agreement with Legacy Health to acquire select assets of its outreach laboratory business, including laboratory facilities and equipment. Labcorp will also...Read more
Expands ResMed’s sleep management software solution, will help sleep labs and physicians more efficiently guide patients into and through diagnosis to long-term treatment Diagnostic management platform is upstream of and complementary to ResMed’s current post-testing AirView and Brightree offerings Somnoware platform will remain an open platform to enable sleep labs, pulmonary function testing facilities, and physicians to view...Read more
| Company | Change | Last Trade |
|---|
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE